Previous 10 | Next 10 |
Summary Cryoport has significantly underperformed the broader market over the past several months, largely due to poor earnings and cash flows. The company has excess cash on its books, but this doesn't make it a great prospect when you consider its continued profitability issues. A...
TORONTO, Feb. 07, 2023 (GLOBE NEWSWIRE) -- EnviroGold Global Limited (CSE: NVRO | OTCQB: ESGLF | FSE: YGK) (“EnviroGold Global” or the “Company”), a Clean Technology Company accelerating the world’s transition to a circular-resource economy, is pleased to a...
Nevro to Present at Citi's 2023 Healthcare Services, Medtech, Tools & HCIT Conference Nevro to Present at Citi's 2023 Healthcare Services, Medtech, Tools & HCIT Conference PR Newswire Wednesday, March 1, 2023 at 8:45 am Eastern Time REDWOOD CI...
Nevro Named to 2023 Bloomberg Gender-Equality Index for Second Consecutive Year PR Newswire Leading Indicator Aimed at Increasing Transparency Surrounding Gender-Related Practices and Policies REDWOOD CITY, Calif. , Jan. 31, 2023 /PRNewswire...
Nevro to Report Fourth Quarter and Full-Year 2022 Financial Results PR Newswire Company to Host Conference Call on Thursday, February 16, 2023 at 1:30 pm PT / 4:30 pm ET REDWOOD CITY, Calif. , Jan. 19, 2023 /PRNewswire/ -- Nevro Corp. ...
TORONTO, Jan. 18, 2023 (GLOBE NEWSWIRE) -- EnviroGold Global Limited (CSE: NVRO | OTCQB: ESGLF | FSE: YGK) (“EnviroGold Global” or the “Company”), a Clean Technology Company accelerating the world’s transition to a circular-resource economy, is pleased to a...
Nevro to Highlight New Clinical Evidence at the 2023 North American Neuromodulation Society (NANS) 26th Annual Meeting PR Newswire REDWOOD CITY, Calif. , Jan. 12, 2023 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company delivering compr...
Nevro Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2022 Revenue and Provides Full-Year 2023 Revenue Guidance PR Newswire Company Announces 2023 Retirement Plans of D. Keith Grossman from Positions of CEO and President; Will Remain as Chairman of ...
Nevro to Present at 41st Annual J.P. Morgan Healthcare Conference PR Newswire Monday, January 9, 2023 at 3:45 pm Pacific Time / 6:45 pm Eastern Time REDWOOD CITY, Calif. , Dec. 19, 2022 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a glob...
Nevro Announces Two Presentations from SENZA-PDN and SENZA-NSRBP Clinical Trials Have Been Accepted for Late-Breaking Abstract Sessions at NANS 2023 Annual Meeting PR Newswire SENZA-PDN 24-Month Follow-Up Results to be Presented on January 14, 2023 SENZA-NSRB...
News, Short Squeeze, Breakout and More Instantly...
Nevro to Report Second-Quarter 2024 Financial Results and Host Earnings Conference Call on August 6, 2024 PR Newswire REDWOOD CITY, Calif. , July 9, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company delivering comprehensive, life-chan...
Nevro to Present at Truist Securities MedTech Conference PR Newswire REDWOOD CITY, Calif. , June 11 , 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chr...
Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08 PR Newswire REDWOOD CITY, Calif. , May 24, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the trea...